Skip to main content
Premium Trial:

Request an Annual Quote

Clarient Licenses Biomarker for Cancer Dx, Theranostics

NEW YORK (GenomeWeb News) – Clarient today said that it has licensed from Minerva Biotechnologies exclusive rights to develop and commercialize a test that identifies the MUC1* protein, a biomarker that researchers believe may be associated with the spread of several cancers.

Clarient believes the biomarker could be used for diagnosis, therapy selection, and monitoring of drug effectiveness in solid tumors. Aliso Viejo, Calif.-based Clarient expects a further year of development to thoroughly evaluate the predictive value of measuring MUC1* in a patient's sample.

"Early research has also demonstrated that MUC1* may play a role in developing resistance to cancer drugs, which means if you can block MUC1*, you may be able to overcome resistance to a drug and, once again, offer that therapy," Clarient CEO Ron Andrews said in a statement.

Andrews added that once the firm is done evaluating and validating a test targeting the MUC1* biomarker, it will aim to commercialize the test through its national pathology distribution network.

The firms noted that there currently are no therapies on the market targeting the MUC1* biomarker.

Terms of the alliance were not disclosed.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.